Summit Securities Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-200
Closed -$13K 349
2014
Q4
$13K Buy
+200
New +$13K ﹤0.01% 370